Goals of neoadjuvant therapy; pCR as an endpoint in TNBC
How to improve pCR in TNBC
Optimizing taxanes in TNBC
DNA damaging agents
Is there a role for adjuvant therapy in TNBC in 2020?
Take home messages
Summarizing “Neoadjuvant vs adjuvant approaches in early TNBC” ESMO presentation is discussed.